No, rabies vaccine and rabies immune globulin (RIG) should NOT be administered in the same arm on day 0
HRIG should never be administered in the same syringe or in the same anatomical site as the first vaccine dose 1, 2, 3. This is a critical safety requirement to prevent interference with active antibody production.
Administration Protocol
Day 0 (First Dose):
- RIG administration: Infiltrate the full calculated dose (20 IU/kg) around and into the wound(s) if anatomically feasible 2
- Any remaining RIG volume must be injected IM at a site distant from vaccine administration 1, 2
- Vaccine administration: Give in the deltoid (adults) or anterolateral thigh (children) - this must be a different anatomical site from where RIG is given 1, 2
Subsequent Vaccine Doses (Days 3,7,14):
- Subsequent doses CAN be given in the same anatomic location where RIG was previously administered 1
- This flexibility only applies after day 0 - the critical separation requirement is only for the first simultaneous administration
Rationale
The separation requirement exists because RIG can partially suppress active antibody production 1, 2, 3. By administering them at different anatomical sites on day 0, you:
- Ensure immediate passive immunity from RIG at the wound site
- Allow unimpeded active immune response from the vaccine
- Prevent local interference between the two products
Common Pitfalls to Avoid
- Never use the same syringe for both products 1, 3
- Never inject into the gluteal area for vaccine - this results in lower neutralizing antibody titers 1, 2
- Do not exceed the recommended RIG dose (20 IU/kg) as this can suppress vaccine response 1, 2
- Do not administer RIG intravenously - it is for IM use only 3
The evidence from ACIP guidelines is unequivocal and consistent across multiple iterations 1, 2, with FDA labeling reinforcing these same restrictions 3. This is a non-negotiable safety requirement for rabies post-exposure prophylaxis.